Takeda Throws In Towel On Diet Pill Development With Amylin
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical and Amylin Pharmaceuticals Aug. 5 announced an end to the development of pramlintide/metreleptin for weight loss